PATENT CLAIM ANALYSIS

Application Number: 16033002
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["435", "006000"]

Abstract:
The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.

Claim (Index 21):
The method of  claim 17 , wherein the method comprises introducing a donor polynucleotide into the bacterial cell or the eukaryotic cell.

Metadata:
- Claim Count in Document: 82.0
- Percentile: 95.0
- Lexical Diversity: 2.25424
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16033005', '16033016', '14685504', '15803424', '15138604']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4833198689051912
- 35 USC 102 Novelty (BERT): 0.6784568373569815
- Combined Prediction Score: 0.5028335657503702
- Mean Citation Score: 763.21018
- Max Citation Score: 769.0730599999997
- Similarity Product: 639.7939418687616

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test